RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
-3.06%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$517M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,482
Reduced
1,461
Closed
51
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$76.4M |
| 2 |
S&P Global
SPGI
|
$74M |
| 3 |
Tesla
TSLA
|
$64.3M |
| 4 |
Microsoft
MSFT
|
$47M |
| 5 |
Constellation Energy
CEG
|
$29.7M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
$31.7M |
| 4 |
Exelon
EXC
|
$26.1M |
| 5 |
Abbott
ABT
|
$24.4M |
Sector Composition
| 1 | Technology | 24.75% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Pliant Therapeutics
PLRX
$106M
| $160K | ﹤0.01% |
22,867
+523
| +2% | +$3.66K |
|
2802
Quantum Corp
QMCO
$101M
| $160K | ﹤0.01% |
3,534
-42
| -1% | -$1.9K |
|
2803
InfuSystem Holdings
INFU
$210M
| $159K | ﹤0.01% |
16,232
+5,021
| +45% | +$49.2K |
|
2804
Rekor Systems
REKR
$139M
| $158K | ﹤0.01% |
34,677
+4,803
| +16% | +$21.9K |
|
|
OYST
2805
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $158K | ﹤0.01% |
13,531
+2,568
| +23% | +$30K |
|
2806
FTC Solar
FTCI
$94.6M
| $157K | ﹤0.01% |
3,183
+1,715
| +117% | +$84.6K |
|
2807
Lineage Cell Therapeutics
LCTX
$283M
| $157K | ﹤0.01% |
101,742
-18,692
| -16% | -$28.8K |
|
2808
Adverum Biotechnologies
ADVM
$74.3M
| $156K | ﹤0.01% |
11,921
-967
| -8% | -$12.7K |
|
|
CLPR
2809
Clipper Realty
CLPR
$71.4M
| $156K | ﹤0.01% |
17,247
+213
| +1% | +$1.93K |
|
2810
Stereotaxis
STXS
$262M
| $156K | ﹤0.01% |
41,897
+2,886
| +7% | +$10.7K |
|
2811
Cue Biopharma
CUE
$59.7M
| $155K | ﹤0.01% |
31,768
-36
| -0.1% | -$176 |
|
2812
Precision BioSciences
DTIL
$58.6M
| $153K | ﹤0.01% |
1,655
+73
| +5% | +$6.75K |
|
2813
RxSight
RXST
$366M
| $153K | ﹤0.01% |
+12,353
| New | +$153K |
|
2814
The ONE Group
STKS
$84.2M
| $153K | ﹤0.01% |
14,589
+3,800
| +35% | +$39.9K |
|
|
PSTX
2815
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $153K | ﹤0.01% |
34,064
+3,137
| +10% | +$14.1K |
|
2816
CEL-SCI Corp
CVM
$71.2M
| $152K | ﹤0.01% |
1,293
-16
| -1% | -$1.88K |
|
|
EPZM
2817
DELISTED
Epizyme, Inc
EPZM
| $150K | ﹤0.01% |
130,067
+17,351
| +15% | +$20K |
|
|
KG
2818
Kestrel Group, Ltd.
KG
$199M
| $149K | ﹤0.01% |
3,089
-141
| -4% | -$6.8K |
|
|
CASA
2819
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $149K | ﹤0.01% |
32,974
-602
| -2% | -$2.72K |
|
|
EAR
2820
DELISTED
Eargo, Inc. Common Stock
EAR
| $149K | ﹤0.01% |
1,409
+443
| +46% | +$46.8K |
|
2821
Target Hospitality
TH
$873M
| $148K | ﹤0.01% |
24,622
-514
| -2% | -$3.09K |
|
2822
Akebia Therapeutics
AKBA
$830M
| $147K | ﹤0.01% |
205,062
-6,053
| -3% | -$4.34K |
|
2823
Tourmaline Bio
TRML
$775M
| $147K | ﹤0.01% |
1,494
+64
| +4% | +$6.3K |
|
2824
Taysha Gene Therapies
TSHA
$884M
| $146K | ﹤0.01% |
22,389
+2,619
| +13% | +$17.1K |
|
|
BFX
2825
DELISTED
BowFlex Inc.
BFX
| $145K | ﹤0.01% |
35,145
-2,951
| -8% | -$12.2K |
|